
We explore the integration of biotechnology and information technology in healthcare innovation. The convergence of these fields has revolutionized diagnostics, therapeutics and patient management. Biotechnology advancements, such as genomics and molecular diagnostics, enable personalized medicine, while information technology facilitates data management and analysis. The integration also extends healthcare access through telemedicine and remote patient monitoring, enhancing healthcare delivery in underserved areas. Challenges include data security and privacy concerns. Looking ahead, the integration of biotechnology and information technology holds immense potential for further healthcare innovation, transforming patient outcomes and healthcare delivery.
Citation: Leelakrishna Reddy, Segun Akinola. Transforming healthcare with the synergy of biotechnology and information technology[J]. AIMS Bioengineering, 2023, 10(4): 421-439. doi: 10.3934/bioeng.2023025
[1] | Induni N. Weerarathna, Anurag Luharia . Exploring the nexus of biomedical science and robots for enhanced clinical outcomes—a literature review. AIMS Bioengineering, 2024, 11(1): 1-17. doi: 10.3934/bioeng.2024001 |
[2] | Meher Langote, Saniya Saratkar, Praveen Kumar, Prateek Verma, Chetan Puri, Swapnil Gundewar, Palash Gourshettiwar . Human–computer interaction in healthcare: Comprehensive review. AIMS Bioengineering, 2024, 11(3): 343-390. doi: 10.3934/bioeng.2024018 |
[3] | Mujibullah Sheikh, Pranita S. Jirvankar . Harnessing artificial intelligence for enhanced nanoparticle design in precision oncology. AIMS Bioengineering, 2024, 11(4): 574-597. doi: 10.3934/bioeng.2024026 |
[4] | P. Mora-Raimundo, M. Manzano, M. Vallet-Regí . Nanoparticles for the treatment of osteoporosis. AIMS Bioengineering, 2017, 4(2): 259-274. doi: 10.3934/bioeng.2017.2.259 |
[5] | Daniel Calle, Duygu Yilmaz, Sebastian Cerdan, Armagan Kocer . Drug delivery from engineered organisms and nanocarriers as monitored by multimodal imaging technologies. AIMS Bioengineering, 2017, 4(2): 198-222. doi: 10.3934/bioeng.2017.2.198 |
[6] | Pawel Jajesniak, Tuck Seng Wong . From genetic circuits to industrial-scale biomanufacturing: bacterial promoters as a cornerstone of biotechnology. AIMS Bioengineering, 2015, 2(3): 277-296. doi: 10.3934/bioeng.2015.3.277 |
[7] | David Raymond, Induni Nayodhara Weerarathna, John Kessellie Jallah, Praveen Kumar . Nanoparticles in biomedical implants: Pioneering progress in healthcare. AIMS Bioengineering, 2024, 11(3): 391-438. doi: 10.3934/bioeng.2024019 |
[8] | Natalia Fullana, Victoria Braña, Juan José Marizcurrena, Danilo Morales, Jean-Michel Betton, Mónica Marín, Susana Castro-Sowinski . Identification, recombinant production and partial biochemical characterization of an extracellular cold-active serine-metalloprotease from an Antarctic Pseudomonas isolate. AIMS Bioengineering, 2017, 4(3): 386-401. doi: 10.3934/bioeng.2017.3.386 |
[9] | Esther Menendez, Paula Garcia-Fraile, Raul Rivas . Biotechnological applications of bacterial cellulases. AIMS Bioengineering, 2015, 2(3): 163-182. doi: 10.3934/bioeng.2015.3.163 |
[10] | Segun Akinola, Leelakrishna Reddy . Nanoscale antenna systems: Transforming wireless communications and biomedical applications. AIMS Bioengineering, 2023, 10(3): 300-330. doi: 10.3934/bioeng.2023019 |
We explore the integration of biotechnology and information technology in healthcare innovation. The convergence of these fields has revolutionized diagnostics, therapeutics and patient management. Biotechnology advancements, such as genomics and molecular diagnostics, enable personalized medicine, while information technology facilitates data management and analysis. The integration also extends healthcare access through telemedicine and remote patient monitoring, enhancing healthcare delivery in underserved areas. Challenges include data security and privacy concerns. Looking ahead, the integration of biotechnology and information technology holds immense potential for further healthcare innovation, transforming patient outcomes and healthcare delivery.
The integration of biotechnology and information technology has revolutionized healthcare, leading to significant advancements in diagnosis, treatment and patient care [1]. This synergistic combination has paved the way for a new era of healthcare innovation, offering tremendous potential for improving health outcomes and transforming the delivery of medical services [2]. Biotechnology involves the application of biological knowledge and techniques to develop products and processes that benefit human health [3]. On the other hand, information technology encompasses the use of computers, software and data analysis to manage and exchange information effectively. The convergence of these two fields has resulted in ground-breaking solutions that have far-reaching implications for healthcare [4]. The biotechnology application is applied to many sectors for implementations (see Figure 1). The Biotechnology finds diverse applications across industries, driving innovation in healthcare, agriculture, energy and environmental solutions, benefiting society. The key focus is on healthcare and related industries. The integration of biotechnology and information technology has enabled the development of innovative medical devices, precision medicine approaches, telehealth services, electronic health records and sophisticated data analytics tools [5]. These advancements have enhanced medical diagnostics, personalized treatment plans, remote patient monitoring and streamlined healthcare operations. Moreover, this integration has fostered collaboration among multidisciplinary teams, including healthcare professionals, biologists, engineers and computer scientists, to address complex healthcare challenges [6]. The significance of this integration for healthcare innovation cannot be overstated. It has facilitated the rapid and accurate diagnosis of diseases, leading to early interventions and improved patient outcomes. By leveraging the power of big data and artificial intelligence, healthcare providers can extract valuable insights from vast amounts of patient information, enabling personalized medicine tailored to individual needs. Furthermore, the integration of biotechnology and information technology has expanded access to healthcare services, particularly in remote and underserved areas, through telemedicine and mobile health applications [7]. The objectives of this review are to examine the current state of integration between biotechnology and information technology in healthcare, highlight the key innovations and advancements in the field and assess the impact of this integration on patient care and healthcare systems. We will also explore the challenges and prospects of this convergence and discuss potential ethical, legal and social implications.
The scope of this review will encompass various aspects of the integration.
Biotechnology-enabled medical devices and diagnostics
Applications of information technology in personalized medicine
Telehealth and remote patient monitoring systems
Electronic health records and health information exchange
Data analytics and artificial intelligence in healthcare
Collaborative research and development efforts in biotechnology and information technology
Regulatory considerations and ethical implications of the integration.
By comprehensively examining the integration of biotechnology and information technology in healthcare, we aim to provide insights into the transformative potential of this synergy and its implications for future healthcare innovation.
Biotechnology plays a pivotal role in revolutionizing healthcare by offering innovative solutions in diagnostics, therapeutics and personalized medicine [8]. It encompasses a wide range of techniques and technologies that leverage biological systems, living organisms or their components to develop products and processes that improve human health. In this section, we will explore the multifaceted contributions of biotechnology in healthcare and discuss recent advancements in biotechnological tools and techniques. Diagnostics: Biotechnology has transformed diagnostic approaches, enabling faster and more accurate identification of diseases. Molecular diagnostics, based on biotechnological tools, have revolutionized disease detection and monitoring [9]. Techniques such as polymerase chain reaction (PCR), gene sequencing and microarray analysis allow for the identification and characterization of genetic mutations, pathogens and biomarkers associated with various diseases.
These advancements have paved the way for personalized diagnostics and precision medicine, facilitating targeted therapies and improved patient outcomes [10]. Therapeutics: Biotechnology has revolutionized therapeutic interventions by providing innovative treatment options. Recombinant DNA technology allows for the production of therapeutic proteins, such as insulin, growth factors and monoclonal antibodies, with high specificity and efficacy [11]. Biopharmaceuticals derived from biotechnology offer enhanced therapeutic potential, addressing complex diseases like cancer, autoimmune disorders and genetic conditions. Moreover, gene editing techniques, such as CRISPR-Cas9, provide the ability to modify genetic material, opening doors for potential cures for genetic diseases [12].
Personalized Medicine: The integration of biotechnology and information technology has facilitated personalized medicine, tailoring treatment strategies to an individual's specific characteristics. Advances in genomics, proteomics and metabolomics allow for comprehensive profiling of an individual's genetic makeup, protein expression patterns and metabolic profiles [13]. This wealth of data enables healthcare providers to develop personalized treatment plans, predict drug responses and optimize therapeutic outcomes. Pharmacogenomics, for example, utilizes genetic information to determine the most effective and safe medication for an individual, minimizing adverse drug reactions and optimizing treatment efficacy.
Next-Generation Sequencing (NGS): NGS technologies have revolutionized the field of genomics by enabling rapid and cost-effective sequencing of entire genomes [14]. These techniques provide valuable insights into genetic variations, disease-causing mutations and potential therapeutic targets. NGS has transformed diagnostics, enabling the identification of rare genetic diseases and facilitating early intervention and personalized treatment approaches [15],[16]. Gene Editing: The development of precise gene editing tools, such as CRISPR-Cas9, has revolutionized the field of biotechnology. CRISPR-Cas9 allows for targeted modifications of specific genes, opening up possibilities for correcting genetic defects and developing new therapies [17]. This technique has the potential to treat genetic disorders, enhance disease resistance and modify cellular functions for therapeutic purposes.
Microarray Technology: Microarray technology enables the simultaneous analysis of thousands of genes or proteins, providing valuable insights into gene expression patterns, protein interactions and biomarker discovery [18]. Microarrays have facilitated diagnostic advancements, enabling the identification of disease signatures and the development of personalized treatment strategies. Synthetic biology combines engineering principles with biological components to design and construct new biological systems or modify existing ones. This field has applications in drug development, biofuel production and the creation of engineered organisms for medical purposes. Synthetic biology offers new avenues for the development of therapeutics, biomaterials and biotechnological tools [19].
Biotechnology's influence extends to agriculture, where precision breeding techniques, including genome editing, have improved crop yields, reduced pesticide use and enhanced disease resistance. Furthermore, the harnessing of synthetic biology has enabled the production of biofuels and biodegradable materials, contributing to sustainability goals, biofuel production innovations may indirectly support sustainable healthcare facilities, reducing emissions and promoting eco-friendly practices.
In healthcare, personalized medicine is becoming increasingly feasible thanks to advancements in genomics, allowing treatments to be tailored to an individual's genetic makeup. Therapeutic developments like mRNA vaccines have shown their potential to address global health challenges, such as the COVID-19 pandemic.
Biotechnological innovations also offer promise in addressing environmental concerns. For instance, bioremediation techniques leverage genetically engineered organisms to clean up pollution and mitigate environmental damage.
These remarkable advancements in biotechnology are continually shaping the future of healthcare, agriculture, environmental conservation and industry, heralding a new era of possibilities and solutions to global challenges.
In conclusion, biotechnology plays a pivotal role in healthcare by offering advancements in diagnostics, therapeutics and personalized medicine. Recent biotechnological tools and techniques, such as next-generation sequencing, gene editing, microarray technology and synthetic biology, have revolutionized healthcare practices. These advancements hold great promise for improving patient care, developing targeted therapies and paving the way for precision medicine approaches.
Information technology (IT) has become indispensable in modern healthcare systems, playing a crucial role in patient management, healthcare delivery and data-driven decision-making. In this section, we will explore the importance of information technology in healthcare systems and discuss key components such as electronic health records (EHRs), health information exchange and data analytics [20]. Importance of Information Technology in Healthcare Systems: Information technology has transformed healthcare systems by enhancing the efficiency, accuracy and accessibility of patient information. It enables seamless communication and collaboration between healthcare professionals, improves patient safety and streamlines administrative processes [21]. Here are some key aspects of the importance of IT in healthcare.
IT systems allow healthcare organizations to store, manage and retrieve vast amounts of patient data efficiently. This includes medical histories, laboratory results, medication records and imaging studies [22]. Digital storage of patient information eliminates the need for physical records, reduces the risk of data loss and facilitates quick and secure access to patient data when needed.
IT systems play a critical role in medication management, reducing the risk of errors and adverse drug events. Computerized physician order entry (CPOE) systems and barcode medication administration systems help prevent medication errors by ensuring accurate prescribing, dispensing and administration of medications [23]. IT systems also enable real-time monitoring of patient's vital signs and automated alerts for abnormal values, enhancing patient safety and timely interventions.
IT systems facilitate seamless communication and collaboration between healthcare providers across different locations and disciplines. Electronic communication platforms, such as secure messaging and teleconferencing, enable quick consultations, exchange of medical information, and remote collaborations [24]. This improves care coordination, especially in complex cases requiring multidisciplinary expertise.
IT enables remote access to healthcare services through telehealth and telemedicine platforms. Patients can receive virtual consultations, access medical advice and receive follow-up care from the comfort of their homes. Telehealth has proven particularly beneficial in rural and underserved areas, improving access to healthcare and reducing geographical barriers [25].
Electronic Health Records (EHRs): EHRs are digital versions of patients' medical records, containing comprehensive information about their health history, diagnoses, treatments and laboratory results. EHRs offer numerous benefits [26]:
EHRs consolidate patient information from various sources into a single, accessible platform. This ensures healthcare providers have a comprehensive view of the patient's medical history, enabling informed decision-making and personalized care.
EHRs allow for real-time updates and immediate access to patient data, enabling timely decision-making, reducing duplication of tests and facilitating better care coordination between healthcare providers.
EHR systems aim to be interoperable, enabling seamless exchange of patient information across different healthcare organizations and systems. This promotes care continuity, enables smooth transitions between healthcare settings and facilitates health information exchange.
Biotechnology-enabled medical devices and diagnostics
Applications of information technology in personalized medicine
Telehealth and remote patient monitoring systems
Electronic health records and health information exchange
Data analytics and artificial intelligence in healthcare
Collaborative research and development efforts in biotechnology and information technology
Regulatory considerations and ethical implications of the integration.
It has the potential to transform healthcare in several ways:
Data analytics enables the identification of patterns, trends and risk factors that can predict disease outcomes or complications. This facilitates early interventions, personalized treatment plans and proactive patient management.
By analyzing population-level data, data analytics helps identify health trends, risk factors and gaps in healthcare delivery. This supports the development of targeted interventions, preventive strategies and resource allocation for improved population health outcomes.
Data analytics enables healthcare organizations to monitor and measure the quality of care provided. It allows for the identification of areas for improvement, benchmarks performance against industry standards and supports evidence-based decision-making for quality enhancement.
The synergy of Artificial Intelligence (AI) and Internet of Things (IoT) revolutionizes industries by enabling smart devices, predictive analytics and real-time data integration. In healthcare, AI and IoT empower remote patient monitoring and personalized treatment.
In conclusion, information technology is of paramount importance in healthcare systems and patient management. It enhances the efficiency, accuracy and accessibility of patient information, improves patient safety and facilitates seamless communication and collaboration between healthcare providers. Key components of IT in healthcare include electronic health records (EHRs), health information exchange and data analytics, which enable centralized patient information, interoperability, coordinated care and data-driven decision-making. Leveraging the power of information technology offers immense potential for improving healthcare outcomes, enhancing patient experiences and transforming healthcare delivery.
The convergence of biotechnology and information technology has led to ground-breaking advancements in healthcare. This convergence brings together the power of biological systems and data-driven technologies, creating synergies that enhance biotechnological processes and revolutionize data management in healthcare [27]. In this section, we will explore the areas of convergence between biotechnology and information technology and discuss how information technology enhances biotechnological processes and data management in healthcare.
The field of genomics, which involves the study of an organism's complete set of DNA (genome), has greatly benefited from information technology [28]. High-throughput DNA sequencing technologies generate vast amounts of genomic data. Bioinformatics, a discipline that combines biology and computer science, utilizes information technology to store, analyze and interpret genomic data. It involves developing algorithms, databases and computational tools to extract valuable insights from genomic data, including identifying disease-causing mutations, predicting drug responses and understanding the genetic basis of diseases.
The convergence of biotechnology and information technology enables the integration and analysis of diverse biological datasets. By leveraging data integration techniques and sophisticated analytical tools, researchers can combine genomic, proteomic and metabolomic data to gain a comprehensive understanding of biological systems [29],[30]. This integrated approach helps identify biomarkers, pathways and therapeutic targets, leading to the development of personalized medicine strategies and targeted therapies.
Information technology enables the development of computational models and simulations to predict biological phenomena and optimize biotechnological processes. Computational models can simulate the behavior of biological systems, such as protein interactions, cellular processes and drug interactions [31]. These models aid in drug discovery, protein engineering and optimizing bioprocesses, reducing the need for costly and time-consuming experimental iterations.
Information technology expedites the drug discovery process by facilitating virtual screening, molecular modeling and structure-based drug design. Advanced computational tools help identify potential drug candidates, predict their efficacy and optimize their chemical structures [32]. This reduces the time and cost required for preclinical and clinical trials, leading to faster development of novel therapeutics.
The convergence of biotechnology and information technology plays a crucial role in precision medicine, tailoring treatments to individual patients based on their unique genetic profiles, environmental factors and lifestyle choices. Information technology enables the analysis and interpretation of patient data, including genomic information, clinical records and environmental factors, to develop personalized treatment plans. This improves treatment efficacy, minimizes adverse drug reactions and optimizes patient outcomes.
Information technology supports the optimization of bioprocesses involved in biopharmaceutical production. Advanced software systems monitor and control parameters such as temperature, pH and nutrient supply, ensuring optimal conditions for cell growth and product synthesis. Real-time monitoring, data analytics and artificial intelligence techniques enable predictive maintenance, process optimization and yield improvement, reducing costs and enhancing efficiency in bio-manufacturing [33].
Information technology enhances data management in healthcare through the implementation of electronic health records (EHRs). EHRs streamline the collection, storage and retrieval of patient data, enabling healthcare providers to access comprehensive and up-to-date medical information. EHRs facilitate efficient data sharing among different healthcare settings, improving care coordination and continuity.
Platforms utilize information technology to enable secure sharing of patient data between healthcare organizations [34]. HIE ensures that critical patient information, including medical history, medications and allergies, is readily accessible to authorized healthcare providers. This improves care transitions, emergency care and overall patient safety.
Information technology enables robust data analytics in healthcare, helping extract valuable insights from large volumes of patient data. Data analytics techniques, such as machine learning and artificial intelligence, can identify patterns, predict disease outcomes and optimize treatment plans. These insights support evidence-based decision-making, personalized medicine and population health management.
Information technology also plays a crucial role in ensuring the privacy and security of patient data. Robust cybersecurity measures, encryption techniques, access controls and audit trails are implemented to protect sensitive patient information. Compliance with regulations such as the Health Insurance Portability and Accountability Act (HIPAA) ensures the secure handling of patient data [35].
In conclusion, the convergence of biotechnology and information technology brings significant advancements to healthcare. It enhances biotechnological processes by accelerating drug discovery, enabling precision medicine and optimizing bioprocesses. Information technology also revolutionizes data management in healthcare through electronic health records, health information exchange and advanced analytics. The synergy between biotechnology and information technology holds great promise for improving patient care, advancing medical research and driving innovation in healthcare delivery.
The integration of biotechnology and information technology has given rise to numerous applications that have transformed healthcare and led to significant innovations [36]. This section will explore specific examples where the convergence of these fields has revolutionized healthcare, including telemedicine, wearable devices, remote patient monitoring and precision medicine.
Telemedicine utilizes information technology to provide healthcare services remotely, bridging the gap between patients and healthcare providers. It enables virtual consultations, remote diagnosis and treatment, bringing healthcare to patients' homes.
Telemedicine overcomes geographical barriers, allowing patients in remote or underserved areas to access healthcare services [37]. It ensures that individuals in rural locations or areas with limited healthcare facilities can receive timely medical advice and consultations.
Telemedicine eliminates the need for travel and reduces wait times, resulting in cost and time savings for patients. It also minimizes the burden on healthcare infrastructure and resources, optimizing their utilization.
Telemedicine incorporates biotechnological tools such as wearable devices, sensors and remote monitoring systems. These devices collect patient data, such as vital signs, glucose levels or cardiac activity, and transmit it to healthcare providers in real time [38]. This allows for proactive management of chronic conditions, early detection of complications and timely interventions.
For instance, there are cases where a patient with diabetes can use a wearable device that continuously monitors their blood glucose levels [39]. The device transmits the data to the healthcare provider, who can remotely monitor the patient's condition, provide timely advice on medication adjustments and offer lifestyle recommendations.
Wearable devices, including smartwatches, fitness trackers and biosensors, have gained popularity for monitoring personal health and wellness. These devices incorporate biotechnological sensors and integrate with information technology platforms, enabling real-time data collection and analysis [40].
Wearable devices can track vital signs, physical activity, sleep patterns and other health-related metrics. These devices provide users with valuable insights into their well-being, promoting healthy habits and empowering individuals to take charge of their health.
Wearable devices can aid in the management of chronic diseases by monitoring symptoms, medication adherence and activity levels. They enable individuals and healthcare providers to track disease progression, identify triggers and adjust treatment plans accordingly.
By continuously monitoring physiological parameters, wearable devices can detect early signs of health issues or abnormalities [41]. Timely alerts and notifications can be sent to healthcare providers or individuals, prompting further evaluation or intervention.
A case wearable fitness tracker can monitor heart rate, sleep patterns and physical activity levels. By integrating it with a smartphone app, it provides users with actionable insights, encouraging exercise, healthy sleep habits and stress management.
Remote patient monitoring utilizes biotechnological sensors and information technology to monitor patients' health outside of traditional healthcare settings [42]. It involves collecting and transmitting data on vital signs, symptoms or disease-specific metrics to healthcare providers for analysis and intervention. The integration of biotechnology and information technology in RPM offers several advantages:
RPM enables healthcare providers to remotely monitor patients' health parameters on an ongoing basis. This provides a comprehensive view of the patient's condition, facilitates early detection of complications and enables timely interventions.
RPM empowers patients to actively participate in their healthcare by monitoring their health and sharing data with healthcare providers [43]. This fosters patient engagement, adherence to treatment plans and enhances outcomes.
By closely monitoring patients post-discharge, RPM can detect early signs of deterioration, allowing for timely interventions and reducing the risk of hospital readmissions.
A case-patient recovering from heart surgery can be equipped with a wearable device that continuously monitors their heart rate, blood pressure and oxygen saturation levels [44]. The data is transmitted to healthcare providers who can remotely monitor the patient's progress, detect any abnormalities and intervene if necessary.
It focuses on understanding the genetic, environmental and lifestyle factors that influence disease development and response to treatments. The integration of biotechnology and information technology in precision medicine offers the following benefits:
Precision medicine allows healthcare providers to develop personalized treatment plans based on an individual's genetic profile, biomarker analysis and clinical data. This facilitates targeted therapies, reduces adverse effects and optimizes treatment outcomes.
Information technology platforms can analyze large-scale genomic and clinical datasets, providing predictive insights into disease susceptibility, treatment response and disease progression. This helps healthcare providers make informed decisions and tailor interventions accordingly.
Biotechnology and information technology are instrumental in precision medicine research and drug development [46]. Computational models, genomic analysis tools and advanced analytics enable the identification of new drug targets, discovery of biomarkers and development of targeted therapies.
In oncology, precision medicine utilizes genomic analysis to identify specific mutations or genetic markers that drive a patient's cancer [47]. This information helps healthcare providers select targeted therapies that are more likely to be effective for that individual, improving treatment outcomes.
In conclusion, the integration of biotechnology and information technology has led to transformative applications in healthcare. Telemedicine, wearable devices, remote patient monitoring and precision medicine are just a few examples where this convergence has revolutionized patient care, disease management and medical research. These applications enhance access to healthcare, facilitate proactive monitoring, enable personalized treatments and empower individuals to actively engage in their health and well-being. The integration of biotechnology and information technology continues to pave the way for innovative solutions that enhance healthcare outcomes and improve quality of life.
While the integration of biotechnology and information technology brings remarkable advancements to healthcare, the translation of biotechnology to commercial development has faced several challenges, including (see Figure 2) [48] commercializing biotechnology confronts hurdles like regulatory complexities, funding gaps, ethical concerns and technology adoption, demanding strategic solutions for progress. It also presents challenges and ethical considerations that need to be addressed. Some of the key challenges and ethical considerations associated [49] with this convergence are:
Privacy and Data Security: The integration of biotechnology and information technology involves the collection, storage and analysis of vast amounts of sensitive patient data. Maintaining patient privacy and ensuring data security are critical. Healthcare organizations must implement robust cybersecurity measures, encryption techniques, access controls and data anonymization practices to protect patient information from unauthorized access or breaches. Striking a balance between data sharing for research purposes and preserving patient privacy is a complex challenge that requires careful consideration.
Informed Consent: The integration of biotechnology and information technology often requires the collection and use of personal health data [50]. Obtaining informed consent from patients for using and sharing their data is crucial. Patients should be fully informed about how their data will be used, who will have access to it and the potential benefits and risks involved. Consent mechanisms should be transparent, and patients should have the right to control their data and revoke consent if desired.
Data Accuracy and Reliability: Biotechnological tools generate vast amounts of data, and information technology processes and analyzes this data for medical decision-making [51]. Ensuring the accuracy, reliability and quality of the data is crucial for sound clinical decisions. Healthcare providers and researchers need to address issues related to data completeness, standardization and data integrity to minimize errors and biases in data analysis [52].
Health Inequities and Access:
The integration of biotechnology and information technology has the potential to exacerbate existing health inequities if access to technology or digital infrastructure is unevenly distributed. Ensuring equitable access to biotechnological tools and information technology platforms is essential to prevent further disparities in healthcare outcomes [53]. Efforts should be made to bridge the digital divide, especially in underserved communities, to ensure that advancements in healthcare benefit all individuals regardless of their socioeconomic status.
Regulatory and Legal Frameworks:
The rapid pace of innovation in biotechnology and information technology presents challenges for regulatory and legal frameworks to keep up [54]. Regulations need to be updated and adapted to address emerging technologies, data privacy concerns and ethical considerations. It is important to establish clear guidelines and standards for data protection, consent processes and responsible use of technology to ensure the ethical and responsible integration of biotechnology and information technology in healthcare.
Ethical Use of Data: The integration of biotechnology and information technology generates a wealth of data that holds tremendous potential for medical research and innovation [55]. However, the ethical use of data is paramount. Data should be used responsibly and transparently, with respect for patient privacy and the principles of beneficence and non-maleficence. Safeguards should be in place to prevent the misuse or misinterpretation of data, and data ownership and intellectual property rights should be clearly defined. Addressing these challenges and ethical considerations requires a collaborative effort from healthcare providers, researchers, policymakers and regulatory bodies. It is important to establish guidelines, codes of conduct and best practices that promote the responsible and ethical integration of biotechnology and information technology, ensuring the benefits are maximized while protecting patient rights and privacy. Continuous evaluation and adaptation of ethical frameworks are necessary to keep pace with technological advancements and evolving societal values.
The integration of biotechnology and information technology in healthcare is a dynamic field that continues to evolve and holds immense promise for the future. Several future trends and potential advancements are anticipated in this area, including:
Artificial Intelligence (AI) and Machine Learning: AI and machine learning algorithms are expected to play an increasingly important role in analyzing complex biological data, identifying patterns and making predictions. These technologies have the potential to revolutionize disease diagnosis, drug discovery and personalized medicine. Internet of Medical Things (IoMT): The IoMT, a network of interconnected medical devices and sensors will continue to expand, enabling real-time monitoring, remote patient care and data-driven interventions. This will enhance personalized healthcare, improve patient outcomes and facilitate proactive disease management. Blockchain Technology: Blockchain technology holds promise in ensuring secure and decentralized storage of healthcare data. It can enhance data privacy and interoperability and enable secure health information exchange while giving patients greater control over their data. Integration of Omics Data: The integration of genomic, proteomic, metabolomic and other omics data will advance precision medicine approaches, enabling personalized therapies, predicting disease outcomes and identifying biomarkers for early detection and intervention. In summary, the integration of biotechnology and information technology has ushered in a new era of healthcare innovation. Throughout this review, we explored the various applications, challenges and ethical considerations associated with this convergence. We discussed the significant impact this integration has had on healthcare, including the rise of telemedicine, wearable devices, remote patient monitoring and precision medicine. These advancements have improved access to healthcare, facilitated proactive monitoring, enabled personalized treatments and empowered individuals to actively engage in their health and well-being. However, we also recognized the challenges surrounding privacy, data security, consent and health inequities. It is crucial to address these challenges through robust regulations, ethical frameworks and responsible data management practices to ensure the responsible integration of biotechnology and information technology in healthcare. Looking ahead, the future holds exciting prospects for this integration, with the potential for AI, machine learning, the IoMT, blockchain technology and omics data integration to further revolutionize healthcare delivery, disease management and medical research.
In conclusion, the integration of biotechnology and information technology has transformed healthcare, offering unprecedented opportunities for precision medicine, remote patient care and data-driven decision-making. The synergistic collaboration between these fields has led to groundbreaking innovations, improved patient outcomes and enhanced healthcare delivery. Embracing this integration, while addressing the associated challenges and ethical considerations, will pave the way for a future where personalized, accessible and effective healthcare becomes a reality for all.
The authors declare they have not used Artificial Intelligence (AI) tools in the creation of this article.
[1] |
Ginsburg GS, McCarthy JJ (2001) Personalized medicine: revolutionizing drug discovery and patient care. TRENDS Biotechnol 19: 491-496. https://doi.org/10.1016/S0167-7799(01)01814-5 ![]() |
[2] |
Seyhan AA, Carini C (2019) Are innovation and new technologies in precision medicine paving a new era in patients centric care?. J Transl Med 17: 1-28. https://doi.org/10.1186/s12967-019-1864-9 ![]() |
[3] |
Ibañez E, Cifuentes A (2013) Benefits of using algae as natural sources of functional ingredients. J Sci Food Agr 93: 703-709. https://doi.org/10.1002/jsfa.6023 ![]() |
[4] |
Ellis BJ, Boyce WT, Belsky J, et al. (2011) Differential susceptibility to the environment: An evolutionary–neurodevelopmental theory. Dev Psychopathol 23: 7-28. https://doi.org/10.1017/S0954579410000611 ![]() |
[5] |
Bentahar, soumia, rofia abada, and pr ykhlef nadia. “biotechnology: definitions, types and main applications.YMER.” . ![]() |
[6] |
Akinola S, Telukdarie A (2023) Sustainable digital transformation in healthcare: Advancing a digital vascular health innovation solution. Sustainability 15: 10417. https://doi.org/10.3390/su151310417 ![]() |
[7] |
Källander K, Tibenderana JK, Akpogheneta OJ, et al. (2013) Mobile health (mHealth) approaches and lessons for increased performance and retention of community health workers in low-and middle-income countries: a review. J Med Internet Res 15: e17. https://doi.org/10.2196/jmir.2130 ![]() |
[8] |
Dwivedi S, Purohit P, Misra R, et al. (2017) Diseases and molecular diagnostics: a step closer to precision medicine. Indian J Clin Biochem 32: 374-398. https://doi.org/10.1007/s12291-017-0688-8 ![]() |
[9] |
Khiyami MA, Almoammar H, Awad YM, et al. (2014) Plant pathogen nanodiagnostic techniques: forthcoming changes?. Biotechnol Biotechnol Equip 28: 775-785. https://doi.org/10.1080/13102818.2014.960739 ![]() |
[10] |
Abdelhalim H, Berber A, Lodi M, et al. (2022) Artificial intelligence, healthcare, clinical genomics, and pharmacogenomics approaches in precision medicine. Front Genet 13: 929736. https://doi.org/10.3389/fgene.2022.929736 ![]() |
[11] | Sekhon BS (2010) Biopharmaceuticals: an overview. Thai J Pharm Sci 34: 1-19. https://doi.org/10.2147/BS.S16120 |
[12] |
Kesik-Brodacka M (2018) Progress in biopharmaceutical development. Biotechnol Appl Biochem 65: 306-322. https://doi.org/10.1002/bab.1617 ![]() |
[13] |
Verma M (2012) Personalized medicine and cancer. J Pers Med 2: 1-14. https://doi.org/10.3390/jpm2010001 ![]() |
[14] |
Xuan J, Yu Y, Qing T, et al. (2013) Next-generation sequencing in the clinic: promises and challenges. Cancer Lett 340: 284-295. https://doi.org/10.1016/j.canlet.2012.11.025 ![]() |
[15] |
Renkema KY, Stokman MF, Giles RH, et al. (2014) Next-generation sequencing for research and diagnostics in kidney disease. Nat Rev Nephrol 10: 433-444. https://doi.org/10.1038/nrneph.2014.95 ![]() |
[16] |
Li H, Yang Y, Hong W, et al. (2020) Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects. Signal Transduction Targeted Ther 5: 1. https://doi.org/10.1038/s41392-019-0089-y ![]() |
[17] |
Pontén F, Schwenk JM, Asplund A, et al. (2011) The human protein atlas as a proteomic resource for biomarker discovery. J Intern Med 270: 428-446. https://doi.org/10.1111/j.1365-2796.2011.02427.x ![]() |
[18] |
Andrianantoandro E, Basu S, Karig DK, et al. (2006) Synthetic biology: new engineering rules for an emerging discipline. Mol Syst Biol 2: 2006.0028. https://doi.org/10.1038/msb4100073 ![]() |
[19] |
Liu AP, Appel EA, Ashby PD, et al. (2022) The living interface between synthetic biology and biomaterial design. Nat Mater 21: 390-397. https://doi.org/10.1038/s41563-022-01231-3 ![]() |
[20] |
Jha AK, Doolan D, Grandt D, et al. (2008) The use of health information technology in seven nations. Int J Med Inf 77: 848-854. https://doi.org/10.1016/j.ijmedinf.2008.06.007 ![]() |
[21] |
Liu W, Manias E, Gerdtz M (2014) The effects of physical environments in medical wards on medication communication processes affecting patient safety. Health Place 26: 188-198. https://doi.org/10.1016/j.healthplace.2013.12.017 ![]() |
[22] |
Dash S, Shakyawar S K, Sharma M, et al. (2019) Big data in healthcare: management, analysis and future prospects. J Big Data 6: 1-25. https://doi.org/10.1186/s40537-019-0217-0 ![]() |
[23] |
Wang JK, Herzog NS, Kaushal R, et al. (2007) Prevention of pediatric medication errors by hospital pharmacists and the potential benefit of computerized physician order entry. Pediatrics 119: e77-e85. https://doi.org/10.1542/peds.2006-0034 ![]() |
[24] |
Rosset C, Rosset A, Ratib O (2005) General consumer communication tools for improved image management and communication in medicine. J Digit Imaging 18: 270-279. https://doi.org/10.1007/s10278-005-6703-2 ![]() |
[25] |
Shalash A, Spindler M, Cubo E (2021) Global perspective on telemedicine for Parkinson's disease. J Parkinson's Dis 11: S11-S18. https://doi.org/10.3233/JPD-202411 ![]() |
[26] |
Burton LC, Anderson GF, Kues IW (2004) Using electronic health records to help coordinate care. Milbank Q 82: 457-481. https://doi.org/10.1111/j.0887-378X.2004.00318.x ![]() |
[27] |
De Guire E, Bartolo L, Brindle R, et al. (2019) Data-driven glass/ceramic science research: Insights from the glass and ceramic and data science/informatics communities. J Am Ceram Soc 102: 6385-6406. https://doi.org/10.1111/jace.16677 ![]() |
[28] |
Green ED, Guyer MS (2011) Charting a course for genomic medicine from base pairs to bedside. Nature 470: 204-213. https://doi.org/10.1038/nature09764 ![]() |
[29] |
Subramanian I, Verma S, Kumar S, et al. (2020) Multi-omics data integration, interpretation, and its application. Bioinf Biol Insights 14: 1177932219899051. https://doi.org/10.1177/1177932219899051 ![]() |
[30] |
Graw S, Chappell K, Washam CL, et al. (2021) Multi-omics data integration considerations and study design for biological systems and disease. Mol Omics 17: 170-185. https://doi.org/10.1039/D0MO00041H ![]() |
[31] |
Ren LH, Ding YS, Shen YZ, et al. (2008) Multi-agent-based bio-network for systems biology: protein–protein interaction network as an example. Amino acids 35: 565-572. https://doi.org/10.1007/s00726-008-0081-2 ![]() |
[32] |
Willmann S, Lippert J, Schmitt W (2005) From physicochemistry to absorption and distribution: predictive mechanistic modelling and computational tools. Expert Opin Drug Metab Toxicol 1: 159-168. https://doi.org/10.1517/17425255.1.1.159 ![]() |
[33] |
Holzinger A, Keiblinger K, Holub P, et al. (2023) AI for life: Trends in artificial intelligence for biotechnology. New Biotechnol 74: 16-24. https://doi.org/10.1016/j.nbt.2023.02.001 ![]() |
[34] |
Esmaeilzadeh P, Mirzaei T (2019) The potential of blockchain technology for health information exchange: experimental study from patients' perspectives. J Med Internet Res 21: e14184. https://doi.org/10.2196/14184 ![]() |
[35] | Dwyer SJ, Weaver AC, Hughes KK (2004) Health insurance portability and accountability act. Secur Issues Digital Med Enterp 72: 9-18. |
[36] |
Liao C, Antaw F, Wuethrich A, et al. (2020) Configurable miniaturized 3D pores for robust single-nanoparticle analysis. Small Struct 1: 2000011. https://doi.org/10.1002/sstr.202000011 ![]() |
[37] |
Krishna VN, Managadi K, Smith M, et al. (2017) Telehealth in the delivery of home dialysis care: catching up with technology. Adv Chronic kidney Dis 24: 12-16. https://doi.org/10.1053/j.ackd.2016.11.014 ![]() |
[38] |
Akinola S, Reddy L (2023) Nanoscale antenna systems: Transforming wireless communications and biomedical applications. AIMS Bioeng 10: 300-330. https://doi.org/10.3934/bioeng.2023019 ![]() |
[39] |
Lee H, Hong YJ, Baik S, et al. (2018) Enzyme-based glucose sensor: from invasive to wearable device. Adv Healthc Mater 7: 1701150. https://doi.org/10.1002/adhm.201701150 ![]() |
[40] |
Kim J, Campbell AS, de Ávila BEF, et al. (2019) Wearable biosensors for healthcare monitoring. Nature Biotechnol 37: 389-406. https://doi.org/10.1038/s41587-019-0045-y ![]() |
[41] |
Iqbal SMA, Mahgoub I, Du E, et al. (2021) Advances in healthcare wearable devices. NPJ Flex Electron 5: 9. https://doi.org/10.1038/s41528-021-00107-x ![]() |
[42] |
Atreja A, Francis S, Kurra S, et al. (2019) Digital medicine and evolution of remote patient monitoring in cardiac electrophysiology: a state-of-the-art perspective. Curr Treat Option Cardiovasc Med 21: 1-10. https://doi.org/10.1007/s11936-019-0787-3 ![]() |
[43] |
Sasangohar F, Davis E, Kash BA, et al. (2018) Remote patient monitoring and telemedicine in neonatal and pediatric settings: Scoping literature review. J Med Internet Res 20: e295. https://doi.org/10.2196/jmir.9403 ![]() |
[44] |
Patel V, Orchanian-Cheff A, Wu R (2021) Evaluating the validity and utility of wearable technology for continuously monitoring patients in a hospital setting: systematic review. JMIR mHealth uHealth 9: e17411. https://doi.org/10.2196/17411 ![]() |
[45] |
Ahmed Z, Mohamed K, Zeeshan S, et al. (2020) Artificial intelligence with multi-functional machine learning platform development for better healthcare and precision medicine. Database 2020: baaa010. https://doi.org/10.1093/database/baaa010 ![]() |
[46] |
Blumenthal GM, Mansfield E, Pazdur R (2016) Next-generation sequencing in oncology in the era of precision medicine. Jama Oncol 2: 13-14. https://doi.org/10.1001/jamaoncol.2015.4503 ![]() |
[47] |
Gonzalez-Angulo AM, Hennessy BTJ, Mills GB (2010) Future of personalized medicine in oncology: a systems biology approach. J Clin Oncol 28: 2777. https://doi.org/10.1200/JCO.2009.27.0777 ![]() |
[48] |
Liao C, Xiao S, Wang X (2023) Bench-to-bedside: Translational development landscape of biotechnology in healthcare. Health Sci Rev 7: 100097. https://doi.org/10.1016/j.hsr.2023.100097 ![]() |
[49] |
Muller H, Mayrhofer MT, Van Veen EB, et al. (2021) The ten commandments of ethical medical AI. Computer 54: 119-123. https://doi.org/10.1109/MC.2021.3074263 ![]() |
[50] |
Meingast M, Roosta T, Sastry S (2006) Security and privacy issues with health care information technology. 2006 International Conference of the IEEE Engineering in Medicine and Biology Society 2006: 5453-5458. https://doi.org/10.1109/IEMBS.2006.260060 ![]() |
[51] |
Kusiak A, Kern JA, Kernstine KH, et al. (2000) Autonomous decision-making: a data mining approach. IEEE T Inf Technol B 4: 274-284. https://doi.org/10.1109/4233.897059 ![]() |
[52] | Bowman S (2013) Impact of electronic health record systems on information integrity: quality and safety implications. Perspect Health Inf Manag 10: 1c. |
[53] |
Ibrahim H, Liu X, Zariffa N, et al. (2021) Health data poverty: an assailable barrier to equitable digital health care. Lancet Digit Health 3: e260-e265. https://doi.org/10.1016/S2589-7500(20)30317-4 ![]() |
[54] | Marchant GE (2011) The Growing Gap Between Emerging Technologies and The Law. Netherlands: Springer. https://doi.org/10.1007/978-94-007-1356-7 |
[55] | Vermesan O, Friess P (2014) Internet of Things Applications-From Research and Innovation to Market Deployment. UK: Taylor & Francis. https://doi.org/10.1201/9781003338628 |